Your browser doesn't support javascript.
loading
Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression.
Junge, Alexandra; Bacher, Ulrike; Mueller, Beatrice U; Keller, Peter; Solenthaler, Max; Pabst, Thomas.
Afiliação
  • Junge A; Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Switzerland.
  • Bacher U; Department of Hematology, Inselspital, University Hospital Bern, University of Bern, Switzerland.
  • Mueller BU; Department of Biomedical Research, Inselspital, University Hospital Bern, University of Bern, Switzerland.
  • Keller P; Department of Hematology, Inselspital, University Hospital Bern, University of Bern, Switzerland.
  • Solenthaler M; Department of Hematology, Regionalspital, Langenthal, Switzerland.
  • Pabst T; Department of Hematology, Inselspital, University Hospital Bern, University of Bern, Switzerland.
Hematol Oncol ; 2018 Jun 03.
Article em En | MEDLINE | ID: mdl-29862539
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Hematol Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Hematol Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Suíça